Literature DB >> 3093082

The c-myc oncogene perturbs B lymphocyte development in E-mu-myc transgenic mice.

W Y Langdon, A W Harris, S Cory, J M Adams.   

Abstract

Transgenic mice bearing a c-myc oncogene subjugated to the lymphoid-specific immunoglobulin heavy chain enhancer (E mu) develop clonal B lymphoid malignancies, but most young E mu-myc mice lack malignant clones. Their prelymphomatous state has allowed us to examine how constitutive c-myc expression influences B cell development. We find that early stages are overrepresented, even before birth. Pre-B cells of polyclonal origin increase greatly, while B cells develop in reduced number. Both the pre-B and the B cells appear to be in an active state, since they are larger than normal and a greater fraction are in the cell cycle. Enforced myc expression has thus favored proliferation over maturation. Hence, a normal function of c-myc may be to regulate differentiation as well as to promote cell cycling.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093082     DOI: 10.1016/0092-8674(86)90361-2

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  143 in total

Review 1.  The Max network gone mad.

Authors:  T A Baudino; J L Cleveland
Journal:  Mol Cell Biol       Date:  2001-02       Impact factor: 4.272

2.  B lymphocyte-specific c-Myc expression stimulates early and functional expansion of the vasculature and lymphatics during lymphomagenesis.

Authors:  Alanna Ruddell; Pau Mezquita; Kimberly A Brandvold; Andrew Farr; Brian M Iritani
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

3.  Hematologic disease induced in BALB/c mice by a bcr-abl retrovirus is influenced by the infection conditions.

Authors:  A G Elefanty; S Cory
Journal:  Mol Cell Biol       Date:  1992-04       Impact factor: 4.272

4.  Depletion of c-myc with specific antisense sequences reverses the transformed phenotype in ras oncogene-transformed NIH 3T3 cells.

Authors:  M D Sklar; E Thompson; M J Welsh; M Liebert; J Harney; H B Grossman; M Smith; E V Prochownik
Journal:  Mol Cell Biol       Date:  1991-07       Impact factor: 4.272

5.  Complex regulation of the immunoglobulin mu heavy-chain gene enhancer: microB, a new determinant of enhancer function.

Authors:  B Nelsen; T Kadesch; R Sen
Journal:  Mol Cell Biol       Date:  1990-06       Impact factor: 4.272

Review 6.  MYC: connecting selective transcriptional control to global RNA production.

Authors:  Theresia R Kress; Arianna Sabò; Bruno Amati
Journal:  Nat Rev Cancer       Date:  2015-09-18       Impact factor: 60.716

7.  Transgenic mice bearing the human c-myc gene activated by an immunoglobulin enhancer: a pre-B-cell lymphoma model.

Authors:  E V Schmidt; P K Pattengale; L Weir; P Leder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-08       Impact factor: 11.205

8.  The novel ETS factor TEL2 cooperates with Myc in B lymphomagenesis.

Authors:  Monica Cardone; Ayten Kandilci; Cintia Carella; Jonas A Nilsson; Jennifer A Brennan; Sema Sirma; Ugur Ozbek; Kelli Boyd; John L Cleveland; Gerard C Grosveld
Journal:  Mol Cell Biol       Date:  2005-03       Impact factor: 4.272

9.  Downregulation of FOXP1 is required during germinal center B-cell function.

Authors:  Ainara Sagardoy; Jose I Martinez-Ferrandis; Sergio Roa; Karen L Bunting; María Angela Aznar; Olivier Elemento; Rita Shaknovich; Lorena Fontán; Vicente Fresquet; Ignacio Perez-Roger; Eloy F Robles; Linde De Smedt; Xavier Sagaert; Ari Melnick; Jose A Martinez-Climent
Journal:  Blood       Date:  2013-04-11       Impact factor: 22.113

10.  Puma and to a lesser extent Noxa are suppressors of Myc-induced lymphomagenesis.

Authors:  E M Michalak; E S Jansen; L Happo; M S Cragg; L Tai; G K Smyth; A Strasser; J M Adams; C L Scott
Journal:  Cell Death Differ       Date:  2009-01-16       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.